BackgroundAtazanavir/ritonavir is recommended as a preferred second-line antiretroviral regimen in children older than 3 months, alternatively to lopinavir/ritonavir. We performed a systematic review
Report of Dolutegravir & Rilpivirine Combination Drug Market is currently supplying a comprehensive analysis of many things which are liable for economy growth and factors which could play an importan
Full details of the SelleckChem FDA-approved drug library used for the screening assay as outlined in our manuscript. Dataset includes the names of the 1,954 drugs along with the following information
